These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 37695111
1. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Beheshti Maal A, Shahrbaf MA, Sadri B, Hossein-Khannazer N, Mansournia MA, Vosough M. J Crohns Colitis; 2024 Mar 01; 18(3):360-374. PubMed ID: 37695111 [Abstract] [Full Text] [Related]
2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M. World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964 [Abstract] [Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
4. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. Silva J, Brito BS, Silva INN, Nóbrega VG, da Silva MCSM, Gomes HDN, Fortes FM, Pimentel AM, Mota J, Almeida N, Surlo VC, Lyra A, Rocha R, Santana GO. Biomed Res Int; 2019 Feb 01; 2019():7604939. PubMed ID: 30834274 [Abstract] [Full Text] [Related]
5. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Navaneethan U, Shen B. Inflamm Bowel Dis; 2010 Sep 01; 16(9):1598-619. PubMed ID: 20198712 [Abstract] [Full Text] [Related]
6. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Kilic Y, Kamal S, Jaffar F, Sriranganathan D, Quraishi MN, Segal JP. Inflamm Bowel Dis; 2024 Feb 01; 30(2):230-239. PubMed ID: 37042969 [Abstract] [Full Text] [Related]
8. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis. Zhang Y, Gao X, He Z, Jia H, Chen M, Wang X, Hong L, Cui Y, Wan J. Liver Int; 2022 Aug 01; 42(8):1814-1822. PubMed ID: 35689520 [Abstract] [Full Text] [Related]
9. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L. Aliment Pharmacol Ther; 2014 Jul 01; 40(1):3-15. PubMed ID: 24815622 [Abstract] [Full Text] [Related]
10. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks. Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S. Inflamm Bowel Dis; 2023 Sep 01; 29(9):1477-1487. PubMed ID: 36040402 [Abstract] [Full Text] [Related]
11. The Prevalence and Associated Risk Factors of Erectile Dysfunction in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Wu X, Zhang Y, Zhang W, Liu G, Huang H, Jiang H, Zhang X. J Sex Med; 2022 Jun 01; 19(6):950-960. PubMed ID: 35491378 [Abstract] [Full Text] [Related]